Skip to main content

Market Overview

UPDATE: Bank Of America Reiterates On Humana Following Investor Day


In a report published Friday, Bank of America analyst Kevin Fischbeck reiterated a Neutral rating on Humana (NYSE: HUM), and raised the price target from $146.00 to $150.00.

In the report, Bank of America noted, “Yesterday HUM held its biennial Investor Day. Overall, the tone was positive but the company stopped short of blessing the market's view that there would be a dramatic earnings ramp in 2016, and instead shifted the conversation to the company's capabilities and positioning over a longer horizon. This is likely a function of typical management conservatism around unknown 2016 MA rates, with the company reiterating prior comments that it is willing to target a modestly lower pretax margin if it will drive enrollment meaningfully higher and maximize total gross profit dollars over the LT. Overall, we came away incrementally more positive, as HUM's STARS and trend benders should allow it to offset potential rate pressure in the ST and continue to position for strong MA growth and we are raising our PO to $150.”

Humana closed on Thursday at $141.12.

Latest Ratings for HUM

Jan 2021RBC CapitalUpgradesSector PerformOutperform
Nov 2020SVB LeerinkMaintainsOutperform
Nov 2020Credit SuisseMaintainsOutperform

View More Analyst Ratings for HUM
View the Latest Analyst Ratings


Related Articles (HUM)

View Comments and Join the Discussion!

Posted-In: Bank of America Kevin FischbeckAnalyst Color Price Target Analyst Ratings

Latest Ratings

OSPNSidoti & Co.Upgrades39.0
PLTSidoti & Co.Upgrades48.0
LRCXArgus ResearchMaintains725.0
ROSTLoop CapitalMaintains145.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at